Intelligence · Clinical Development
Pipeline search results
Programs matching “triheptanoin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 14 pipeline programs matching "triheptanoin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
FAT EMULSIONS , Triheptanoin
Lacuna Pharma Pty Ltd
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
1 trial -
Triheptanoin
Ultragenyx UK Limited
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
1 trial -
POST Triheptanoin
Ultragenyx UK Limited
Frontal Lobe Hypometabolism
1 trial -
Triheptanoin
Ultragenyx UK Limited
Glycogen Storage Disease Type V
1 trial -
Triheptanoin
Ultragenyx UK Limited
Glucose Transporter Type 1 Deficiency Syndrome
1 trial -
Triheptanoin
Ultragenyx UK Limited
Adult Polyglucosan Body Disease
1 trial -
Triheptanoin
Ultragenyx UK Limited
Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
1 trial -
Triheptanoin
Ultragenyx UK Limited
ALS
1 trial -
Triheptanoin
Ultragenyx UK Limited
Tarui Disease
1 trial -
Triheptanoin
Ultragenyx UK Limited
Medium-chain Acyl-CoA Dehydrogenase Deficiency
2 trials -
Triheptanoin oil
Ultragenyx UK Limited
Huntington Disease
1 trial -
triheptanoin
Ultragenyx UK Limited
Rett Syndrome
1 trial -
Triheptanoin
Ultragenyx UK Limited
Pyruvate Dehydrogenase Complex Deficiency
1 trial -
Triheptanoin
Ultragenyx UK Limited
Glycogen Storage Disease Type I
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.